Your browser doesn't support javascript.
loading
Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease
Silva, Rafael Rodrigues; Shrestha-Bajracharya, Deena; Almeida-Leite, Camila Megale; Leite, Rômulo; Bahia, Maria Terezinha; Talvani, Andre.
Afiliación
  • Silva, Rafael Rodrigues; Universidade Federal de Ouro Preto. Núcleo de Pesquisas em Ciências Biológicas. Ouro Preto. BR
  • Shrestha-Bajracharya, Deena; Universidade Federal de Ouro Preto. Núcleo de Pesquisas em Ciências Biológicas. Ouro Preto. BR
  • Almeida-Leite, Camila Megale; Universidade Federal de Ouro Preto. Departamento de Ciências Biológicas. Ouro Preto. BR
  • Leite, Rômulo; Universidade Federal de Ouro Preto. Escola de Farmácia. Ouro Preto. BR
  • Bahia, Maria Terezinha; Universidade Federal de Ouro Preto. Núcleo de Pesquisas em Ciências Biológicas. Ouro Preto. BR
  • Talvani, Andre; Universidade Federal de Ouro Preto. Núcleo de Pesquisas em Ciências Biológicas. Ouro Preto. BR
Mem. Inst. Oswaldo Cruz ; 107(4): 513-521, June 2012. ilus, graf
Article en En | LILACS | ID: lil-626446
Biblioteca responsable: BR1.1
ABSTRACT
Trypanosoma cruzi infection induces progressive cardiac inflammation that leads to fibrosis and modifications in the heart architecture and functionality. Statins, such as 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, have been studied due to their pleiotropic roles in modulating the inflammatory response. Our goal was to evaluate the effects of simvastatin on the cardiac inflammatory process using a cardiotropic strain of T. cruzi in a murine model of Chagas cardiomyopathy. C57BL/6 mice were infected with 500 trypomastigotes of the Colombian strain of T. cruzi and treated with an oral dose of simvastatin (20 mg/Kg/day) for one month and inflammatory and morphometric parameters were subsequently evaluated in the serum and in the heart, respectively. Simvastatin reduced the total cholesterol and inflammatory mediators (interferon-gamma, tumour necrosis factor-alpha, CCL2 and CCL5) in the serum and in the heart tissue at 30 days post-infection. Additionally, a proportional reduction in heart weight and inflammatory infiltration was observed. Simvastatin also reduced epimastigote proliferation in a dose-dependent manner in vitro and was able to reduce blood trypomastigotes and heart amastigote nests during the acute phase of Chagas disease in vivo. Based on these data, we conclude that simvastatin exerts a modulatory effect on the inflammatory mediators that are elicited by the Colombian strain of T. cruzi and ameliorates the heart damage that is observed in a murine model of Chagas disease.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: LILACS Asunto principal: Cardiomiopatía Chagásica / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Simvastatina / Miocarditis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mem. Inst. Oswaldo Cruz Asunto de la revista: MEDICINA TROPICAL / PARASITOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Bases de datos: LILACS Asunto principal: Cardiomiopatía Chagásica / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Simvastatina / Miocarditis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mem. Inst. Oswaldo Cruz Asunto de la revista: MEDICINA TROPICAL / PARASITOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Brasil